909 related articles for article (PubMed ID: 22634756)
1. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
Fujimoto A; Totoki Y; Abe T; Boroevich KA; Hosoda F; Nguyen HH; Aoki M; Hosono N; Kubo M; Miya F; Arai Y; Takahashi H; Shirakihara T; Nagasaki M; Shibuya T; Nakano K; Watanabe-Makino K; Tanaka H; Nakamura H; Kusuda J; Ojima H; Shimada K; Okusaka T; Ueno M; Shigekawa Y; Kawakami Y; Arihiro K; Ohdan H; Gotoh K; Ishikawa O; Ariizumi S; Yamamoto M; Yamada T; Chayama K; Kosuge T; Yamaue H; Kamatani N; Miyano S; Nakagama H; Nakamura Y; Tsunoda T; Shibata T; Nakagawa H
Nat Genet; 2012 May; 44(7):760-4. PubMed ID: 22634756
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
3. Distinct Patterns of HBV Integration and
Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
Mathkar PP; Chen X; Sulovari A; Li D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
[TBL] [Abstract][Full Text] [Related]
7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Chen YL; Jeng YM; Chang CN; Lee HJ; Hsu HC; Lai PL; Yuan RH
Int J Surg; 2014; 12(7):659-65. PubMed ID: 24866078
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
10. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
Ding D; Lou X; Hua D; Yu W; Li L; Wang J; Gao F; Zhao N; Ren G; Li L; Lin B
PLoS Genet; 2012; 8(12):e1003065. PubMed ID: 23236287
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic landscape influences the liver cancer genome architecture.
Hama N; Totoki Y; Miura F; Tatsuno K; Saito-Adachi M; Nakamura H; Arai Y; Hosoda F; Urushidate T; Ohashi S; Mukai W; Hiraoka N; Aburatani H; Ito T; Shibata T
Nat Commun; 2018 Apr; 9(1):1643. PubMed ID: 29691395
[TBL] [Abstract][Full Text] [Related]
12. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H; Shibata T
Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
[TBL] [Abstract][Full Text] [Related]
14. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
15. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.
Murakami Y; Saigo K; Takashima H; Minami M; Okanoue T; Bréchot C; Paterlini-Bréchot P
Gut; 2005 Aug; 54(8):1162-8. PubMed ID: 16009689
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
[TBL] [Abstract][Full Text] [Related]
18. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Sung WK; Zheng H; Li S; Chen R; Liu X; Li Y; Lee NP; Lee WH; Ariyaratne PN; Tennakoon C; Mulawadi FH; Wong KF; Liu AM; Poon RT; Fan ST; Chan KL; Gong Z; Hu Y; Lin Z; Wang G; Zhang Q; Barber TD; Chou WC; Aggarwal A; Hao K; Zhou W; Zhang C; Hardwick J; Buser C; Xu J; Kan Z; Dai H; Mao M; Reinhard C; Wang J; Luk JM
Nat Genet; 2012 May; 44(7):765-9. PubMed ID: 22634754
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
